Colorectal Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colorectal Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 2 (2005), Issue 3 (March)

1. Colorectal cancer screening: prospects for molecular stool analysis.
   Nat Rev Cancer, 5(3): 199-209. [Abstract] [Full-text]
2. Risk of proximal colon neoplasia with distal hyperplastic polyps: a meta-analysis.
   Arch Intern Med, 165(4): 382-90. [Abstract] [Full-text]
3. Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome.
   Obstet Gynecol, 105(3): 569-74. [Abstract] [Full-text]
4. Hypersensitivity in DNA mismatch repair-deficient colon carcinoma cells to DNA polymerase reaction inhibitors.
   Cancer Lett, 220(1): 85-93. [Abstract] [Full-text]
5. Differential staining of dysplastic aberrant crypt foci in the colon facilitates prediction of carcinogenic potentials of chemicals in rats.
   Cancer Lett, 220(1): 67-74. [Abstract] [Full-text]
6. Genetic susceptibility to prostate, breast, and colorectal cancer among Nordic twins.
   Biometrics, 61(1): 55-63. [Abstract] [Full-text]
7. Effect of polyphenolic extracts from red wine and 4-OH-coumaric acid on 1,2-dimethylhydrazine-induced colon carcinogenesis in rats.
   Eur J Nutr, 44(2): 79-84. [Abstract] [Full-text]
8. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
   J Natl Cancer Inst, 97(5): 347-57. [Abstract] [Full-text]
9. Endometrioid adenocarcinoma arising from endometriosis of the mesenterium of the sigmoid colon.
   Jpn J Clin Oncol, 35(3): 154-7. [Abstract] [Full-text]
10. Quercetin decreases the expression of ErbB2 and ErbB3 proteins in HT-29 human colon cancer cells.
    J Nutr Biochem, 16(3): 155-62. [Abstract] [Full-text]
11. Dynamic contrast-enhanced magnetic resonance imaging: a non-invasive method to evaluate significant differences between malignant and normal tissue.
    Eur J Radiol, 53(3): 514-9. [Abstract] [Full-text]
12. Systematic approach to the analysis of cross-sectional imaging for surveillance of recurrent colorectal cancer.
    Eur J Radiol, 53(3): 387-96. [Abstract] [Full-text]
13. Hospital health care resource utilization and costs of colorectal cancer during the first 3-year period following diagnosis in Switzerland.
    Aliment Pharmacol Ther, 21(5): 615-22. [Abstract] [Full-text]
14. Inhibitory effects of feeding with carrots or (-)-falcarinol on development of azoxymethane-induced preneoplastic lesions in the rat colon.
    J Agric Food Chem, 53(5): 1823-7. [Abstract] [Full-text]
15. A phase II trial of ZD1839 (Iressa) 750 mg per day, an oral epidermal growth factor receptor-tyrosine kinase inhibitor, in patients with metastatic colorectal cancer.
    Invest New Drugs, 23(2): 165-70. [Abstract] [Full-text]
16. Role of bax mutations in apoptosis in colorectal cancers with microsatellite instability.
    Am J Clin Pathol, 123(4): 562-70. [Abstract] [Full-text]
17. A novel educational strategy to enhance internal medicine residents' familial colorectal cancer knowledge and risk assessment skills.
    Am J Gastroenterol, 100(3): 677-84. [Abstract] [Full-text]
18. Temporal trends in new diagnoses of colorectal cancer with obstruction, perforation, or emergency admission in Ontario: 1993-2001.
    Am J Gastroenterol, 100(3): 672-6. [Abstract] [Full-text]
19. Colorectal cancer in African Americans.
    Am J Gastroenterol, 100(3): 515-23; discussion 514. [Abstract] [Full-text]
20. Colonic lipoma with florid vascular proliferation and nodule-aggregating appearance related to repeated intussusception.
    Pathol Int, 55(3): 160-4. [Abstract] [Full-text]
21. Significant correlation of morphological remodeling in ulcerative colitis with disease duration and between elevated p53 and p21 expression in rectal mucosa and neoplastic development.
    Pathol Int, 55(3): 113-21. [Abstract] [Full-text]
22. Low daunomycin concentrations protect colorectal cancer cells from hypoxia-induced apoptosis.
    Oncogene, 24(10): 1788-93. [Abstract] [Full-text]
23. Icodextrin reduces postoperative adhesion formation in rats without affecting peritoneal metastasis.
    Surgery, 137(3): 348-54. [Abstract] [Full-text]
24. Rectovaginal fistulas after rectal cancer surgery: Incidence and operative repair by gluteal-fold flap repair.
    Surgery, 137(3): 329-36. [Abstract] [Full-text]
25. Effects of nonselective cyclooxygenase inhibition with low-dose ibuprofen on tumor growth, angiogenesis, metastasis, and survival in a mouse model of colorectal cancer.
    Clin Cancer Res, 11(4): 1618-28. [Abstract] [Full-text]
26. Serum mannan-binding lectin-associated serine protease 2 levels in colorectal cancer: relation to recurrence and mortality.
    Clin Cancer Res, 11(4): 1441-6. [Abstract] [Full-text]
27. Alteration of gene expression in macroscopically normal colonic mucosa from individuals with a family history of sporadic colon cancer.
    Clin Cancer Res, 11(4): 1400-7. [Abstract] [Full-text]
28. Somatic mutations of epidermal growth factor receptor in colorectal carcinoma.
    Clin Cancer Res, 11(4): 1368-71. [Abstract] [Full-text]
29. Social disparities across the continuum of colorectal cancer: a systematic review.
    Cancer Causes Control, 16(1): 55-61. [Abstract] [Full-text]
30. Effects of fermentation products of pro- and prebiotics on trans-epithelial electrical resistance in an in vitro model of the colon.
    Nutr Cancer, 51(1): 102-9. [Abstract] [Full-text]
31. Chemopreventive effects of dietary flaxseed oil on colon tumor development.
    Nutr Cancer, 51(1): 52-8. [Abstract] [Full-text]
32. Possible mechanisms behind the differential effects of soy protein and casein feedings on colon cancer biomarkers in the rat.
    Nutr Cancer, 51(1): 37-44. [Abstract] [Full-text]
33. Serum carotenoids, retinol, and tocopherols, and colorectal cancer risk in a Japanese cohort: effect modification by sex for carotenoids.
    Nutr Cancer, 51(1): 13-24. [Abstract] [Full-text]
34. Focal hyperthermia produces progressive tumor necrosis independent of the initial thermal effects.
    J Gastrointest Surg, 9(3): 410-7. [Abstract] [Full-text]
35. Duodenal cancer arising from the remaining duodenum after pylorus-preserving pancreatoduodenectomy for ampullary cancer in familial adenomatous polyposis.
    J Gastrointest Surg, 9(3): 389-92. [Abstract] [Full-text]
36. Analysis of preoperative prognostic factors for long-term survival after hepatic resection of liver metastasis of colorectal carcinoma.
    J Gastrointest Surg, 9(3): 374-80. [Abstract] [Full-text]
37. Thymidylate synthase gene polymorphism as a prognostic factor for colon cancer.
    J Gastrointest Surg, 9(3): 336-42. [Abstract] [Full-text]
38. The mechanism of microsatellite instability is different in synchronous and metachronous colorectal cancer.
    J Gastrointest Surg, 9(3): 329-35. [Abstract] [Full-text]
39. Systematic follow-up after curative surgery for colorectal cancer in Norway: a population-based audit of effectiveness, costs, and compliance.
    J Gastrointest Surg, 9(3): 320-8. [Abstract] [Full-text]
40. From colonic polyps to colon cancer: pathophysiology, clinical presentation, and diagnosis.
    Clin Lab Med, 25(1): 135-77. [Abstract] [Full-text]
41. IL-8 promotes cell proliferation and migration through metalloproteinase-cleavage proHB-EGF in human colon carcinoma cells.
    Cytokine, 29(6): 275-82. [Abstract] [Full-text]
42. Radioimmunotherapy and colorectal cancer.
    Br J Surg, 92(3): 264-76. [Abstract] [Full-text]
43. Anal intraepithelial neoplasia.
    Br J Surg, 92(3): 277-90. [Abstract] [Full-text]
44. In-contiguity and non-anatomical extension of right hepatic trisectionectomy for liver metastases.
    Br J Surg, 92(3): 340-7. [Abstract] [Full-text]
45. Prospective evaluation of the impact of [18F]fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases.
    Br J Surg, 92(3): 362-9. [Abstract] [Full-text]
46. Genetic testing for maturity onset diabetes of the young: uptake, attitudes and comparison with hereditary non-polyposis colorectal cancer.
    Diabetologia, 48(2): 242-50. [Abstract] [Full-text]
47. Impact of a surgical training programme on rectal cancer outcomes in Stockholm.
    Br J Surg, 92(2): 225-9. [Abstract] [Full-text]
48. Major urinary dysfunction after mesorectal excision for rectal carcinoma.
    Br J Surg, 92(2): 230-4. [Abstract] [Full-text]
49. Risk factors for anastomotic failure after total mesorectal excision of rectal cancer.
    Br J Surg, 92(2): 211-6. [Abstract] [Full-text]
50. Effect of hospital caseload on long-term outcome after standardization of rectal cancer surgery at a national level.
    Br J Surg, 92(2): 217-24. [Abstract] [Full-text]
51. Radioisotope bone scans in the preoperative staging of hepatopancreatobiliary cancer.
    Br J Surg, 92(2): 203-7. [Abstract] [Full-text]
52. Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice.
    Cancer Res, 65(5): 1925-33. [Abstract] [Full-text]
53. Activation of p53 by MDM2 antagonists can protect proliferating cells from mitotic inhibitors.
    Cancer Res, 65(5): 1918-24. [Abstract] [Full-text]
54. Iterative microarray and RNA interference-based interrogation of the SRC-induced invasive phenotype.
    Cancer Res, 65(5): 1814-21. [Abstract] [Full-text]
55. PUMA overexpression induces reactive oxygen species generation and proteasome-mediated stathmin degradation in colorectal cancer cells.
    Cancer Res, 65(5): 1647-54. [Abstract] [Full-text]
56. Tocopherols and the treatment of colon cancer.
    Ann N Y Acad Sci, 1031: 223-33. [Abstract] [Full-text]
57. Effect of vitamin E on gene expression changes in diet-related carcinogenesis.
    Ann N Y Acad Sci, 1031: 169-83. [Abstract] [Full-text]
58. HPV-mediated transformation of the anogenital tract.
    J Clin Virol, 32: S25-33. [Abstract] [Full-text]
59. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness.
    Int J Radiat Oncol Biol Phys, 61(4): 1136-42. [Abstract] [Full-text]
60. Assessment of quality of life in patients with rectal cancer treated by preoperative radiotherapy: a longitudinal prospective study.
    Int J Radiat Oncol Biol Phys, 61(4): 1129-35. [Abstract] [Full-text]
61. Differences in toxicity between men and women treated with 5-fluorouracil therapy for colorectal carcinoma.
    Cancer, 103(6): 1165-71. [Abstract] [Full-text]
62. Selecting patients for flexible sigmoidoscopy. Determinants of incomplete depth of insertion.
    Cancer, 103(6): 1179-85. [Abstract] [Full-text]
63. Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients.
    Br J Cancer, 92(5): 832-7. [Abstract] [Full-text]
64. Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751,871.
    Clin Cancer Res, 11(5): 2063-73. [Abstract] [Full-text]
65. Gene expression profiling of the irinotecan pathway in colorectal cancer.
    Clin Cancer Res, 11(5): 2053-62. [Abstract] [Full-text]
66. Antisense inhibition of methylenetetrahydrofolate reductase reduces cancer cell survival in vitro and tumor growth in vivo.
    Clin Cancer Res, 11(5): 2047-52. [Abstract] [Full-text]
67. Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue.
    Clin Cancer Res, 11(5): 1809-14. [Abstract] [Full-text]
68. Fractional genomic alteration detected by array-based comparative genomic hybridization independently predicts survival after hepatic resection for metastatic colorectal cancer.
    Clin Cancer Res, 11(5): 1791-7. [Abstract] [Full-text]
69. Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer.
    Clin Cancer Res, 11(5): 1757-64. [Abstract] [Full-text]
70. Up-regulation of the peripheral benzodiazepine receptor during human colorectal carcinogenesis and tumor spread.
    Clin Cancer Res, 11(5): 1751-6. [Abstract] [Full-text]
71. Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer.
    Clin Cancer Res, 11(5): 1743-50. [Abstract] [Full-text]
72. Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits.
    Vaccine, 23(17): 2379-87. [Abstract] [Full-text]
73. Colonic neuroendocrine carcinoma in a child.
    Pediatr Radiol, 35(3): 339-43. [Abstract] [Full-text]
74. "Do we really need all that equipment?": factors influencing colorectal cancer screening decisions.
    Qual Health Res, 15(4): 539-54. [Abstract] [Full-text]
75. Methylation profiles of genes utilizing newly developed CpG island methylation microarray on colorectal cancer patients.
    Nucleic Acids Res, 33(5): e46. [Abstract] [Full-text]
76. Peroxisome proliferator-activated receptor expression and activation in normal human colonic epithelial cells and tubular adenomas.
    Scand J Gastroenterol, 40(2): 198-205. [Abstract] [Full-text]
77. Tumour parameters affected by combretastatin A-4 phosphate therapy in a human colorectal xenograft model in nude mice.
    Eur J Cancer, 41(5): 799-806. [Abstract] [Full-text]
78. Retinoblastoma protein is required for efficient colorectal carcinoma cell apoptosis by histone deacetylase inhibitors in the absence of p21Waf.
    Biochem Pharmacol, 69(7): 1059-67. [Abstract] [Full-text]
79. The Estro Regaud Lecture. Radiotherapy in the conservative treatment of rectal cancer. Evidence-based medicine and opinion.
    Radiother Oncol, 74(3): 227-33. [Abstract] [Full-text]
80. Ocular manifestations of familial adenomatous polyposis (Gardner syndrome).
    Ophthalmol Clin North Am, 18(1): 163-6, x. [Abstract] [Full-text]
81. Neuromedin B and its receptor are mitogens in both normal and malignant epithelial cells lining the colon.
    Am J Physiol Gastrointest Liver Physiol, 288(4): G718-28. [Abstract] [Full-text]
82. Bcl-XL small interfering RNA suppresses the proliferation of 5-fluorouracil-resistant human colon cancer cells.
    Mol Cancer Ther, 4(3): 451-6. [Abstract] [Full-text]
83. Epidermal growth factor receptor (EGFR)-related protein inhibits multiple members of the EGFR family in colon and breast cancer cells.
    Mol Cancer Ther, 4(3): 435-42. [Abstract] [Full-text]
84. Does health insurance coverage of office visits influence colorectal cancer testing?
    Cancer Epidemiol Biomarkers Prev, 14(3): 744-7. [Abstract] [Full-text]
85. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.
    Cancer Epidemiol Biomarkers Prev, 14(3): 616-9. [Abstract] [Full-text]
86. XRCC1 and XRCC3 polymorphisms and their role as effect modifiers of unsaturated fatty acids and antioxidant intake on colorectal adenomas risk.
    Cancer Epidemiol Biomarkers Prev, 14(3): 609-15. [Abstract] [Full-text]
87. Risk factors for colorectal cancer in relation to number and size of aberrant crypt foci in humans.
    Cancer Epidemiol Biomarkers Prev, 14(3): 605-8. [Abstract] [Full-text]
88. Risk of prostate cancer in a randomized clinical trial of calcium supplementation.
    Cancer Epidemiol Biomarkers Prev, 14(3): 586-9. [Abstract] [Full-text]
89. Primary non-hodgkin lymphoma of breast in a patient with rectal carcinoma and magnetic resonance spectroscopic examination.
    Breast, 14(2): 169-74. [Abstract] [Full-text]
90. A prospective study of a new immunochemical fecal occult blood test in Korean patients referred for colonoscopy.
    Clin Biochem, 38(4): 395-9. [Abstract] [Full-text]
91. Expression level of thymidylate synthase is a good predictor of chemosensitivity to 5-fluorouracil in colorectal cancer.
    J Gastroenterol, 40(2): 143-7. [Abstract] [Full-text]
92. Genetic variants in the UGT1A6 enzyme, aspirin use, and the risk of colorectal adenoma.
    J Natl Cancer Inst, 97(6): 457-60. [Abstract] [Full-text]
93. Transanal excision of rectal villous adenomas by laparoscopic methods.
    J Laparoendosc Adv Surg Tech A, 15(1): 23-7. [Abstract] [Full-text]
94. Suppression of tumor growth by oncolytic adenovirus-mediated delivery of an antiangiogenic gene, soluble Flt-1.
    Mol Ther, 11(4): 553-62. [Abstract] [Full-text]
95. Effective gene-virotherapy for complete eradication of tumor mediated by the combination of hTRAIL (TNFSF10) and plasminogen k5.
    Mol Ther, 11(4): 531-41. [Abstract] [Full-text]
96. Founder mutation in familial adenomatous polyposis (FAP) in the Balearic Islands.
    Cancer Genet Cytogenet, 158(1): 70-4. [Abstract] [Full-text]
97. Frequency and spectrum of K-RAS codons 12 and 13 mutations in colorectal adenocarcinomas from Taiwan.
    Cancer Genet Cytogenet, 158(1): 55-60. [Abstract] [Full-text]
98. Inducible nitric oxide synthase-dependent DNA damage in mouse model of inflammatory bowel disease.
    Cancer Sci, 96(3): 157-63. [Abstract] [Full-text]
99. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma.
    J Clin Oncol, 23(9): 2038-48. [Abstract] [Full-text]
100. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer.
     J Clin Oncol, 23(9): 1902-10. [Abstract] [Full-text]
101. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial.
     J Clin Oncol, 23(9): 1847-58. [Abstract] [Full-text]
102. Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy.
     J Clin Oncol, 23(9): 1826-38. [Abstract] [Full-text]
103. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
     J Clin Oncol, 23(9): 1819-25. [Abstract] [Full-text]
104. Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.
     J Clin Oncol, 23(9): 1803-10. [Abstract] [Full-text]
105. Testicular uptake and radiation dose in patients receiving Zevalin and Pretarget CC49Fusion protein.
     Cancer Biother Radiopharm, 20(1): 110-8. [Abstract] [Full-text]
106. Pharmacokinetics and clinical evaluation of 125I-radiolabeled humanized CC49 monoclonal antibody (HuCC49deltaC(H)2) in recurrent and metastatic colorectal cancer patients.
     Cancer Biother Radiopharm, 20(1): 16-26. [Abstract] [Full-text]
107. Two modes of microsatellite instability in human cancer: differential connection of defective DNA mismatch repair to dinucleotide repeat instability.
     Nucleic Acids Res, 33(5): 1628-36. [Abstract] [Full-text]
108. Expression of stress response protein glucose regulated protein-78 mediated by c-Myb.
     Int J Biochem Cell Biol, 37(6): 1254-68. [Abstract] [Full-text]
109. Hepatoid malignancy of unknown origin--a diagnostic conundrum: review of literature and case report of collision with adenocarcinoma.
     Surg Oncol, 14(1): 11-25. [Abstract] [Full-text]
110. Clinical utility of a de-functioning loop ileostomy.
     ANZ J Surg, 75(3): 147-51. [Abstract] [Full-text]
111. Genetic changes and clonality relationship between primary colorectal cancers and their pulmonary metastases--an analysis by comparative genomic hybridization.
     Genes Chromosomes Cancer, 43(1): 25-36. [Abstract] [Full-text]
112. Bile acid deoxycholate induces differential subcellular localisation of the PKC isoenzymes beta 1, epsilon and delta in colonic epithelial cells in a sodium butyrate insensitive manner.
     Int J Cancer, 114(6): 887-95. [Abstract] [Full-text]
113. Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study.
     Mod Pathol, 18(4): 511-8. [Abstract] [Full-text]
114. Postoperative mortality and morbidity in French patients undergoing colorectal surgery: results of a prospective multicenter study.
     Arch Surg, 140(3): 278-83, discussion 284. [Abstract] [Full-text]
115. Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cells.
     Cancer Res, 65(6): 2321-9. [Abstract] [Full-text]
116. Expression and nuclear location of the transcriptional repressor Kaiso is regulated by the tumor microenvironment.
     Cancer Res, 65(6): 2224-33. [Abstract] [Full-text]
117. Expression of the carcinoembryonic antigen gene is inhibited by SOX9 in human colon carcinoma cells.
     Cancer Res, 65(6): 2193-8. [Abstract] [Full-text]
118. A proteomics approach to identify changes in protein profiles in pre-cancerous colon.
     Biochem Biophys Res Commun, 330(1): 81-7. [Abstract] [Full-text]
119. DNA damage and aberrant crypt foci as putative biomarkers to evaluate the chemopreventive effect of annatto (Bixa orellana L.) in rat colon carcinogenesis.
     Mutat Res, 582(1): 146-54. [Abstract] [Full-text]
120. Anorectal reconstruction by electrostimulated graciloplasty as part of abdominoperineal resection.
     Eur J Surg Oncol, 31(3): 250-8. [Abstract] [Full-text]
121. Changes in outcome with sphincter preserving surgery for rectal cancer in Korea, 1991-2000.
     Eur J Surg Oncol, 31(3): 242-9. [Abstract] [Full-text]
122. The assessment of urinary function following extended lymph node dissection for colorectal cancer.
     Eur J Surg Oncol, 31(3): 237-41. [Abstract] [Full-text]
123. Survival for rectal cancer patients and international comparisons.
     Ann Oncol, 16(4): 664-72. [Abstract] [Full-text]
124. Soluble markers for the assessment of biological activity with PTK787/ZK 222584 (PTK/ZK), a vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor in patients with advanced colorectal cancer from two phase I trials.
     Ann Oncol, 16(4): 558-65. [Abstract] [Full-text]
125. A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer.
     Ann Oncol, 16(4): 549-57. [Abstract] [Full-text]
126. Hematopoietic cells regulate the angiogenic switch during tumorigenesis.
     Blood, 105(7): 2757-63. [Abstract] [Full-text]
127. MET signalling in primary colon epithelial cells leads to increased transformation irrespective of aberrant Wnt signalling.
     Br J Cancer, 92(6): 1078-83. [Abstract] [Full-text]
128. Assessment of publication bias in the reporting of EUS performance in staging rectal cancer.
     Am J Gastroenterol, 100(4): 808-16. [Abstract] [Full-text]
129. Aspirin-induced nuclear translocation of NFkappaB and apoptosis in colorectal cancer is independent of p53 status and DNA mismatch repair proficiency.
     Br J Cancer, 92(6): 1137-43. [Abstract] [Full-text]
130. SNAIL vs vitamin D receptor expression in colon cancer: therapeutics implications.
     Br J Cancer, 92(6): 985-9. [Abstract] [Full-text]
131. Colonic tumorigenesis in BubR1+/-ApcMin/+ compound mutant mice is linked to premature separation of sister chromatids and enhanced genomic instability.
     Proc Natl Acad Sci U S A, 102(12): 4365-70. [Abstract] [Full-text]
132. Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II study.
     Br J Cancer, 92(6): 1055-62. [Abstract] [Full-text]
133. Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells.
     Proc Natl Acad Sci U S A, 102(12): 4572-7. [Abstract] [Full-text]
134. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention.
     N Engl J Med, 352(11): 1071-80. [Abstract] [Full-text]
135. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.
     N Engl J Med, 352(11): 1092-102. [Abstract] [Full-text]
136. Human colon cancer cells lacking Bax resist curcumin-induced apoptosis and Bax requirement is dispensable with ectopic expression of Smac or downregulation of Bcl-XL.
     Carcinogenesis, 26(4): 713-23. [Abstract] [Full-text]
137. Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis.
     Carcinogenesis, 26(4): 741-51. [Abstract] [Full-text]
138. Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke.
     Carcinogenesis, 26(4): 827-34. [Abstract] [Full-text]
139. Induction of colon tumors in C57BL/6J mice fed MeIQx, IQ, or PhIP followed by dextran sulfate sodium treatment.
     Toxicol Sci, 84(2): 243-8. [Abstract] [Full-text]
140. Evaluating the impact of genetic counseling and testing with signal detection methods.
     J Genet Couns, 14(1): 17-27. [Abstract] [Full-text]
141. Induction of an antigen cascade by diversified subcutaneous/intratumoral vaccination is associated with antitumor responses.
     Clin Cancer Res, 11(6): 2416-26. [Abstract] [Full-text]
142. Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer.
     Clin Cancer Res, 11(6): 2293-9. [Abstract] [Full-text]
143. Cytoplasmic phospholipase A2 levels correlate with apoptosis in human colon tumorigenesis.
     Clin Cancer Res, 11(6): 2265-71. [Abstract] [Full-text]
144. Generation of PRL-3- and PRL-1-specific monoclonal antibodies as potential diagnostic markers for cancer metastases.
     Clin Cancer Res, 11(6): 2195-204. [Abstract] [Full-text]
145. Microsatellite instability testing in colorectal carcinoma: choice of markers affects sensitivity of detection of mismatch repair-deficient tumors.
     Clin Cancer Res, 11(6): 2180-7. [Abstract] [Full-text]
146. Expression of the nm23 homologues nm23-H4, nm23-H6, and nm23-H7 in human gastric and colon cancer.
     J Pathol, 205(5): 623-32. [Abstract] [Full-text]
147. Interobserver agreement in the interpretation of anal intraepithelial neoplasia.
     Cancer, 103(7): 1447-56. [Abstract] [Full-text]
148. The prognostic impact of the ubiquitin ligase subunits Skp2 and Cks1 in colorectal carcinoma.
     Cancer, 103(7): 1336-46. [Abstract] [Full-text]
149. Elevated nuclear maspin expression is associated with microsatellite instability and high tumour grade in colorectal cancer.
     J Pathol, 205(5): 606-14. [Abstract] [Full-text]
150. A kindred with MYH-associated polyposis and pilomatricomas.
     Am J Med Genet A, 134(2): 212-4. [Abstract] [Full-text]
151. CK20 and CK7 protein expression in colorectal cancer: demonstration of the utility of a population-based tissue microarray.
     Hum Pathol, 36(3): 275-81. [Abstract] [Full-text]
152. Self-renewal and cancer of the gut: two sides of a coin.
     Science, 307(5717): 1904-9. [Abstract] [Full-text]
153. The retroperitoneal surface in distal caecal and proximal ascending colon carcinoma: the Cinderella surgical margin?
     J Clin Pathol, 58(4): 426-8. [Abstract] [Full-text]
154. Detection of BRAF mutations in colorectal tumours and peritoneal washings using a mismatch ligation assay.
     J Clin Pathol, 58(4): 372-5. [Abstract] [Full-text]
155. Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy.
     Drug Resist Updat, 7(6): 345-58. [Abstract] [Full-text]
156. Cancer biology and necrotic changes in metastatic lymph nodes and survival of colon cancer patients.
     Am J Surg, 189(3): 364-8. [Abstract] [Full-text]
157. Killing tumor cells: the effect of photodynamic therapy using mono-L-aspartyl chlorine and NS-398.
     Am J Surg, 189(3): 302-5. [Abstract] [Full-text]
158. Hepatectomy plus intraoperative radiofrequency ablation and chemotherapy to treat technically unresectable multiple colorectal liver metastases.
     J Surg Oncol, 90(1): 36-42. [Abstract] [Full-text]
159. Prognostic significance of circumferential margin involvement in rectal adenocarcinoma treated with preoperative chemoradiotherapy and low anterior resection.
     J Surg Oncol, 90(1): 20-5. [Abstract] [Full-text]
160. Energy balance, insulin-related genes and risk of colon and rectal cancer.
     Int J Cancer, 115(1): 148-54. [Abstract] [Full-text]
161. Human FK506 binding protein 65 is associated with colorectal cancer.
     Mol Cell Proteomics, 4(4): 534-44. [Abstract] [Full-text]
162. Lower gastrointestinal symptoms are not predictive of colorectal neoplasia in a faecal occult blood screen-positive population.
     Br J Surg, 92(4): 478-81. [Abstract] [Full-text]
163. Improving colorectal cancer screening by targeting office systems in primary care practices: disseminating research results into clinical practice.
     Arch Intern Med, 165(6): 661-6. [Abstract] [Full-text]
164. Necrotic and apoptotic features of cell death in response to Foscan photosensitization of HT29 monolayer and multicell spheroids.
     Biochem Pharmacol, 69(8): 1167-76. [Abstract] [Full-text]
165. Overexpression of a novel superoxide-producing enzyme, NADPH oxidase 1, in adenoma and well differentiated adenocarcinoma of the human colon.
     Cancer Lett, 221(1): 97-104. [Abstract] [Full-text]
166. Genomic determinants of prognosis in colorectal cancer.
     Cancer Lett, 221(1): 1-9. [Abstract] [Full-text]
167. Impact of age on quality of life in patients with rectal cancer.
     World J Surg, 29(2): 190-7. [Abstract] [Full-text]
168. Bacterial translocation: not a clinically relevant phenomenon in colorectal cancer.
     World J Surg, 29(2): 198-202. [Abstract] [Full-text]
169. Low microsatellite instability is associated with poor prognosis in stage C colon cancer.
     J Clin Oncol, 23(10): 2318-24. [Abstract] [Full-text]
170. Intakes of calcium and vitamin D and risk of colorectal cancer in women.
     Am J Epidemiol, 161(8): 755-64. [Abstract] [Full-text]
171. The value of anal cytology and human papillomavirus typing in the detection of anal intraepithelial neoplasia: a review of cases from an anoscopy clinic.
     Sex Transm Infect, 81(2): 142-6. [Abstract] [Full-text]
172. Metastatic transcriptional pattern revealed by gene expression profiling in primary colorectal carcinoma.
     Int J Cancer, 115(2): 256-62. [Abstract] [Full-text]
173. Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) on adenoma development in the Apc(Min+) mouse and cyclooxygenase-2 in human-derived colon cancer cells.
     Int J Cancer, 115(2): 194-201. [Abstract] [Full-text]
174. CD44 promotes resistance to apoptosis in murine colonic epithelium.
     J Cell Physiol, 203(3): 583-8. [Abstract] [Full-text]

© 2004-2008 Colorectal Cancer Research Today. All Rights Reserved.